{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:14:39Z","timestamp":1762157679437},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T00:00:00Z","timestamp":1345680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00228-012-1376-5","type":"journal-article","created":{"date-parts":[[2012,8,22]],"date-time":"2012-08-22T11:55:17Z","timestamp":1345636517000},"page":"673-681","source":"Crossref","is-referenced-by-count":67,"title":["Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority"],"prefix":"10.1007","volume":"69","author":[{"given":"In\u00eas","family":"Ribeiro-Vaz","sequence":"first","affiliation":[]},{"given":"Joana","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Pascal","family":"Demoly","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Pol\u00f3nia","sequence":"additional","affiliation":[]},{"given":"Eva Rebelo","family":"Gomes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,8,23]]},"reference":[{"issue":"5","key":"1376_CR1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","volume":"113","author":"SGO Johansson","year":"2004","unstructured":"Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF et al (2004) Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immun 113(5):832\u2013836","journal-title":"J Allergy Clin Immun"},{"key":"1376_CR2","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/bmj.327.7425.1222","volume":"327","author":"JK Aronson","year":"2003","unstructured":"Aronson JK, Ferner RE (2003) Joining the DoTS: new approach to classifying adverse drug reactions. Br Med J 327:1222\u20131225","journal-title":"Br Med J"},{"issue":"3","key":"1376_CR3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1398-9995.2009.02248.x","volume":"65","author":"RA Haque","year":"2010","unstructured":"Haque RA, Wagner A, Whisken JA, Nasser SM, Ewan PW (2010) Anaphylaxis to patent blue V: a case series and proposed diagnostic protocol. Allergy 65(3):396\u2013400","journal-title":"Allergy"},{"issue":"1","key":"1376_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.anai.2009.11.005","volume":"104","author":"ZD Mulla","year":"2010","unstructured":"Mulla ZD, Ebrahim MS, Gonzalez JL (2010) Anaphylaxis in the obstetric patient: analysis of a statewide hospital discharge database. Ann Allergy Asthma Immunol 104(1):55\u201359","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1376_CR5","doi-asserted-by":"crossref","unstructured":"International Collaborative Study of Severe Anaphylaxis (2003) Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf12(3):195\u2013202","DOI":"10.1002\/pds.822"},{"key":"1376_CR6","first-page":"564","volume":"169","author":"T Botsis","year":"2011","unstructured":"Botsis T, Ball R (2011) Network analysis of possible anaphylaxis cases reported to the US vaccine adverse event reporting system after H1N1 influenza vaccine. Stud Health Technol Inf 169:564\u2013568","journal-title":"Stud Health Technol Inf"},{"issue":"4","key":"1376_CR7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1365-2125.1993.tb04157.x","volume":"35","author":"MM Klauw Van der","year":"1993","unstructured":"Van der Klauw MM, Stricker BH, Herings RM, Cost WS, Valkenburg HA, Wilson JH (1993) A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 35(4):400\u2013408","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 1","key":"1376_CR8","doi-asserted-by":"crossref","first-page":"72S","DOI":"10.1016\/S0929-693X(99)80250-4","volume":"6","author":"C Marguet","year":"1999","unstructured":"Marguet C, Couderc L, Blanc T, Amar R, Leloet C, Feray D et al (1999) Anaphylaxis in children and adolescents: apropos of 44 patients aged 2\u00a0months to 15\u00a0years. Arch Pediatr 6[Suppl 1]:72S\u201378S","journal-title":"Arch Pediatr"},{"issue":"4","key":"1376_CR9","first-page":"262","volume":"28","author":"M Techapornroong","year":"2010","unstructured":"Techapornroong M, Akrawinthawong K, Cheungpasitporni W, Ruxrungtham K (2010) Anaphylaxis: a ten years inpatient retrospective study. Asian Pac J Allergy Immunol 28(4):262\u2013269","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"12","key":"1376_CR10","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1046\/j.1365-2222.1996.d01-300.x","volume":"26","author":"MM VanDerKlauw","year":"1996","unstructured":"VanDerKlauw MM, Wilson JHP, Stricker BHC (1996) Drug-associated anaphylaxis: 20\u00a0years of reporting in the Netherlands (1974\u20131994) and review of the literature. Clin Exp Allergy 26(12):1355\u20131363","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"1376_CR11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","volume":"117","author":"HA Sampson","year":"2006","unstructured":"Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A et al (2006) Second symposium on the definition and management of anaphylaxis: summary report\u2013Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117(2):391\u2013397","journal-title":"J Allergy Clin Immunol"},{"key":"1376_CR12","unstructured":"Ministry of Health (2004) Order no. 21844\/2004"},{"key":"1376_CR13","unstructured":"World Health Organization (2011). The Uppsala Monitoring Centre, Uppsala. Available at: http:\/\/www.who-umc.org\/ . Accessed 9 Feb 2011"},{"issue":"6","key":"1376_CR14","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2008.09.043","volume":"122","author":"WW Decker","year":"2008","unstructured":"Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A et al (2008) The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 122(6):1161\u20131165","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1376_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/thx.2004.038844","volume":"62","author":"R Gupta","year":"2007","unstructured":"Gupta R, Sheikh A, Strachan DP, Anderson HR (2007) Time trends in allergic disorders in the UK. Thorax 62(1):91\u201396","journal-title":"Thorax"},{"issue":"4","key":"1376_CR16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/ACI.0b013e32832db95a","volume":"9","author":"ML Tang","year":"2009","unstructured":"Tang ML, Osborne N, Allen K (2009) Epidemiology of anaphylaxis. Curr Opin Allergy Clin Immunol 9(4):351\u2013356","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"7247","key":"1376_CR17","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/bmj.320.7247.1441","volume":"320","author":"A Sheikh","year":"2000","unstructured":"Sheikh A, Alves B (2000) Hospital admissions for acute anaphylaxis: time trend study. Br Med J 320(7247):1441","journal-title":"Br Med J"},{"issue":"2","key":"1376_CR18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2008.10.049","volume":"123","author":"WK Liew","year":"2009","unstructured":"Liew WK, Williamson E, Tang ML (2009) Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 123(2):434\u2013442","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1376_CR19","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jaci.2010.02.009","volume":"125","author":"A Gonzalez-Perez","year":"2010","unstructured":"Gonzalez-Perez A, Aponte Z, Vidaurre CF, Rodriguez LA (2010) Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol 125(5):1098\u20131104 e1","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"1376_CR20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.962","volume":"13","author":"M Backstrom","year":"2004","unstructured":"Backstrom M, Mjorndal T, Dahlqvist R (2004) Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf 13(7):483\u2013487","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1376_CR21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00002018-200629040-00004","volume":"29","author":"A Figueiras","year":"2006","unstructured":"Figueiras A, Herdeiro MT, Polonia J, Gestal-Otero JJ (2006) Influence of pharmacists' attitudes on adverse drug reaction reporting\u2014A case-control study in Portugal. Drug Saf 29(4):331\u2013340","journal-title":"Drug Saf"},{"issue":"10","key":"1376_CR22","first-page":"541","volume":"21","author":"DJ Cullen","year":"1995","unstructured":"Cullen DJ, Bates DW, Small SD, Cooper JB, Nemeskal AR, Leape LL (1995) The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 21(10):541\u2013548","journal-title":"Jt Comm J Qual Improv"},{"issue":"2","key":"1376_CR23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.2005-2429","volume":"118","author":"J Le","year":"2006","unstructured":"Le J, Nguyen T, Law AV, Hodding J (2006) Adverse drug reactions among children over a 10-year period. Pediatrics 118(2):555\u2013262","journal-title":"Pediatrics"},{"issue":"3","key":"1376_CR24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/jamia.1998.0050305","volume":"5","author":"AK Jha","year":"1998","unstructured":"Jha AK, Kuperman GJ, Teich JM, Leape L, Shea B, Rittenberg E et al (1998) Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 5(3):305\u2013314","journal-title":"J Am Med Inform Assoc"},{"issue":"7","key":"1376_CR25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00002018-200427070-00004","volume":"27","author":"N Mittmann","year":"2004","unstructured":"Mittmann N, Knowles SR, Gomez M, Fish JS, Cartotto R, Shear NH (2004) Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis. Drug Saf 27(7):477\u2013487","journal-title":"Drug Saf"},{"issue":"2","key":"1376_CR26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaci.2011.03.003","volume":"128","author":"PM Mertes","year":"2011","unstructured":"Mertes PM, Alla F, Trechot P, Auroy Y, Jougla E (2011) Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 128(2):366\u2013373","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1376_CR27","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","volume":"71","author":"BY Thong","year":"2011","unstructured":"Thong BY, Tan TC (2011) Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol 71(5):684\u2013700","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1376_CR28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2165\/11587540-000000000-00000","volume":"34","author":"K Star","year":"2011","unstructured":"Star K, Noren GN, Nordin K, Edwards IR (2011) Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase. Drug Saf 34(5):415\u2013428","journal-title":"Drug Saf"},{"issue":"3","key":"1376_CR29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2003.11.033","volume":"113","author":"K Bohlke","year":"2004","unstructured":"Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS (2004) Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 113(3):536\u2013542","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1376_CR30","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1067\/mai.2002.127860","volume":"110","author":"FE Simons","year":"2002","unstructured":"Simons FE, Peterson S, Black CD (2002) Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 110(4):647\u2013651","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1376_CR31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1365-2125.1999.00943.x","volume":"47","author":"I Martinez-Mir","year":"1999","unstructured":"Martinez-Mir I, Garcia-Lopez M, Palop V, Ferrer JM, Rubio E, Morales-Olivas FJ (1999) A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 47(6):681\u2013688","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"1376_CR32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00228-005-0962-1","volume":"61","author":"S Benahmed","year":"2005","unstructured":"Benahmed S, Picot MC, Hillaire-Buys D, Blayac JP, Dujols P, Demoly P (2005) Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions. Eur J Clin Pharmacol 61(7):537\u2013541","journal-title":"Eur J Clin Pharmacol"},{"issue":"13","key":"1376_CR33","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/archinte.165.13.1500","volume":"165","author":"S Benahmed","year":"2005","unstructured":"Benahmed S, Picot MC, Dumas F, Demoly P (2005) Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactions. Arch Intern Med 165(13):1500\u20131505","journal-title":"Arch Intern Med"},{"issue":"4","key":"1376_CR34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/00313020600820831","volume":"38","author":"I Low","year":"2006","unstructured":"Low I, Stables S (2006) Anaphylactic deaths in Auckland, New Zealand: a review of coronial autopsies from 1985 to 2005. Pathology 38(4):328\u2013332","journal-title":"Pathology"},{"issue":"4","key":"1376_CR35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.all.0000136762.89313.0b","volume":"4","author":"R Pumphrey","year":"2004","unstructured":"Pumphrey R (2004) Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 4(4):285\u2013290","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"8","key":"1376_CR36","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1046\/j.1365-2222.2000.00864.x","volume":"30","author":"RS Pumphrey","year":"2000","unstructured":"Pumphrey RS (2000) Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 30(8):1144\u20131150","journal-title":"Clin Exp Allergy"},{"key":"1376_CR37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/0470861193.ch10","volume":"257","author":"RS Pumphrey","year":"2004","unstructured":"Pumphrey RS (2004) Fatal anaphylaxis in the UK, 1992\u20132001. Novartis Found Symp 257:116\u2013228, discussion 28\u201332, 57\u201360, 276\u2013285","journal-title":"Novartis Found Symp"},{"issue":"8","key":"1376_CR38","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1398-9995.2008.01719.x","volume":"63","author":"IL Silva de","year":"2008","unstructured":"de Silva IL, Mehr SS, Tey D, Tang ML (2008) Paediatric anaphylaxis: a 5\u00a0year retrospective review. Allergy 63(8):1071\u20131076","journal-title":"Allergy"},{"issue":"2","key":"1376_CR39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/adc.2004.069914","volume":"91","author":"SC Braganza","year":"2006","unstructured":"Braganza SC, Acworth JP, McKinnon DR, Peake JE, Brown AF (2006) Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 91(2):159\u2013163","journal-title":"Arch Dis Child"},{"issue":"4","key":"1376_CR40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/adc.85.4.348b","volume":"85","author":"B Alves","year":"2001","unstructured":"Alves B, Sheikh A (2001) Age specific aetiology of anaphylaxis. Arch Dis Child 85(4):348","journal-title":"Arch Dis Child"},{"issue":"7","key":"1376_CR41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/pds.1121","volume":"14","author":"E Kimland","year":"2005","unstructured":"Kimland E, Rane A, Ufer M, Panagiotidis G (2005) Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharmacoepidemiol Drug Saf 14(7):493\u2013499","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1376_CR42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/11319100-000000000-00000","volume":"33","author":"L Aagaard","year":"2010","unstructured":"Aagaard L, Weber CB, Hansen EH (2010) Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf 33(4):327\u2013339","journal-title":"Drug Saf"},{"issue":"3","key":"1376_CR43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2125.2011.04113.x","volume":"73","author":"DB Hawcutt","year":"2012","unstructured":"Hawcutt DB, Mainie P, Riordan A, Smyth RL, Pirmohamed M (2012) Reported paediatric adverse drug reactions in the UK 2000\u20132009. Br J Clin Pharmacol 73(3):437\u2013446","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1376_CR44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SA (2006) Under-reporting of adverse drug reactions: a systematic review. Drug Saf 29(5):385\u2013396","journal-title":"Drug Saf"},{"issue":"1","key":"1376_CR45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/11318970-000000000-00000","volume":"33","author":"M Erlewyn-Lajeunesse","year":"2010","unstructured":"Erlewyn-Lajeunesse M, Dymond S, Slade I, Mansfield HL, Fish R, Jones O et al (2010) Diagnostic utility of two case definitions for anaphylaxis: a comparison using a retrospective case notes analysis in the UK. Drug Saf 33(1):57\u201364","journal-title":"Drug Saf"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1376-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-012-1376-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1376-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:49:00Z","timestamp":1558702140000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-012-1376-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,23]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["1376"],"URL":"https:\/\/doi.org\/10.1007\/s00228-012-1376-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,23]]}}}